These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 66523)

  • 1. Effect of a single dose of dimethyl sulphoxide on renal amyloidosis.
    Ravid M; Keizman IK; Sohar E
    Lancet; 1977 Apr; 1(8014):730-1. PubMed ID: 66523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental murine amyloidosis with dimethyl sulfoxide.
    Kedar I; Greenwald M; Ravid M
    Eur J Clin Invest; 1977 Apr; 7(2):149-50. PubMed ID: 404162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural examination of urinary sediment. Value in renal amyloidosis.
    Winer RL; Wuerker RB; Erickson JO; Cooper WL
    Am J Clin Pathol; 1979 Jan; 71(1):36-9. PubMed ID: 420170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of amyloid fibrils in urinary sediment.
    Derosena R; Koss MN; Pirani CL
    N Engl J Med; 1975 Nov; 293(22):1131-3. PubMed ID: 1186775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effects of dimethyl sulfoxide on the urinary proteins of patients with familial amyloidotic polyneuropathy].
    Tawara S; Araki S; Maeda T; Tsuruoka M
    Nihon Naika Gakkai Zasshi; 1982 Sep; 71(9):1257-63. PubMed ID: 6296247
    [No Abstract]   [Full Text] [Related]  

  • 6. Amyloid fibrils in urinary sediment. Heroin addiction with renal amyloidosis.
    Brus I; Steiner G; Maceda A; Lejano R
    N Y State J Med; 1979 Apr; 79(5):768-71. PubMed ID: 286178
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review.
    Amemori S; Iwakiri R; Endo H; Ootani A; Ogata S; Noda T; Tsunada S; Sakata H; Matsunaga H; Mizuguchi M; Ikeda Y; Fujimoto K
    J Gastroenterol; 2006 May; 41(5):444-9. PubMed ID: 16799886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofixation electrophoresis was highly specific for the diagnosis of renal light-chain amyloidosis.
    Zhou FD; Zhang LX; Yao Y; Wang SX; Zou WZ; Liu G; Chen M; Zhao MH
    Am J Med Sci; 2013 Jan; 345(1):18-21. PubMed ID: 22627261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary protein excretion patterns in reactive (secondary) systemic amyloidosis.
    Teppo AM; Maury CP
    Rheumatol Int; 1988; 8(5):213-7. PubMed ID: 3148996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis.
    Zhu X; Liu F; Liu Y; Liu H; Xu X; Peng Y; Sun L; Yuan S
    Clin Lab; 2011; 57(11-12):947-52. PubMed ID: 22239026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay for urinary amyloid P component.
    Maury CP; Teppo AM
    J Lab Clin Med; 1985 Dec; 106(6):619-23. PubMed ID: 3877774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyloidosis with special reference to kidneys (author's transl)].
    Kopeć J; Kuźniewski M; Rak M
    Przegl Lek; 1980; 37(12):807-12. PubMed ID: 7208969
    [No Abstract]   [Full Text] [Related]  

  • 13. "Amyloid fibrils" in the urinary sediment.
    N Engl J Med; 1978 Mar; 298(13):745-6. PubMed ID: 628404
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary amyloid fibrils in the absence of amyloidosis.
    Linke RP
    Br Med J; 1976 Nov; 2(6046):1259. PubMed ID: 990879
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal amyloidosis and treatment with dimethylsulphoxide (DMSO).
    Giacchino F; Stratta P; Aprato A; Belardi P; Mazzucco G; Cirone U; De Filippi PG; Segoloni G; Vercellone A; Piccoli G
    Minerva Nefrol; 1980; 27(4):559-66. PubMed ID: 7254679
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary findings in renal light chain-derived amyloidosis and light chain deposition disease.
    Melmed GM; Fenves AZ; Stone MJ
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):234-8. PubMed ID: 19525193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis.
    Tencer J; Torffvit O; Grubb A; Björnsson S; Thysell H; Rippe B
    Nephrol Dial Transplant; 1997 Jun; 12(6):1161-6. PubMed ID: 9198045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of light-, electron- and immunofluorescence microscopy of urinary sediment in amyloidosis.
    Orfila C; de Graeve P; Guilhem A; Suc JM
    Virchows Arch A Pathol Anat Histol; 1978 Aug; 379(2):113-8. PubMed ID: 150691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary amyloidosis (AA) and renal disease].
    Torregrosa E; Hernández-Jaras J; Calvo C; Ríus A; García-Pérez H; Maduell F; Vera JM
    Nefrologia; 2003; 23(4):321-6. PubMed ID: 14558331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsuitability of electron microscopic examination of urinary sediment for the diagnosis of amyloidosis.
    Lindner LE; Haber MH
    Am J Clin Pathol; 1979 Jan; 71(1):40-2. PubMed ID: 420171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.